Visionary, inspiring healthcare leader with a proven ability to empower teams and drive collective success. Demonstrated success in enhancing patient access and achieving formulary goals through broad multi-health segment experience. Led initiatives that resulted in top national rankings through stakeholder collaboration, delivering innovative healthcare solutions and measurable outcomes for diverse populations.
Overview
36
36
years of professional experience
Work History
Director, AZ/NM Healthcare Market
Genentech, Inc
Scottsdale, Arizona
05.2020 - Current
Mayo Health System Lead - Leads a multi-million-dollar account through expert customer relationship management, leading to advancing business across key TAs, formulary wins, and a collaborative approach among multiple stakeholders in creating a continuity approach across the system.
Lead a team of multi-diverse stakeholders, including TAMs, BEMs, FRMs, and CEMs. Developed and promoted 10 individuals.
Collaborated across NAD leadership, resulting in the selection of Corey Belken to cover during my sabbatical, creating greater connectivity between the National team and the AZ/NM Ecosystem.
NI West Region Lead - Created a blueprint in working with Inzio partners to drive the uptick of Ocrevus Zunovo, resulting in the AZ Ecosystem ranked in the Top 5 Ecosystems in the Nation based on attainment.
Walmart Ocrevus Zunovo POC - collective stakeholder approach (NAD; Access Solutions; Legal; Marketing; Medical) to develop pilot enabling Ocrevus Zunovo injections at Walmart pharmacy sites in Arizona and Arkansas.
Lead - West Access Forum collaborating across payer stakeholders to create launch strategies, policy changes, and greater access to Genentech therapies.
Lead - National Health Access Threat Team (HATT), resulting in mitigating the negative impact of alternative funding, maximizers/accumulators, and abandonment rates, while creating key resources for the field for greater awareness and education.
Collaborated with local healthcare providers, Employer Coalition, and New Mexico American Lung Association, resulting in 600 lung screenings in marginalized communities with ~20% lung disease detection.
Interim HED AZ/NM - June/July '25 supporting business impact and leading to the advancement/development of people (e.g. Leadership Accelerated Program, Federal Team promotion, NS&CD 'gig.')
2 - Time Pinnacle Recipient for exceptional performance.
2 - Time CMG Accelerator Award Recipient. (e.g. AFP; NAD collaboration-AZ Health Summit)
Interim National Lead - Corporate Account Management
Genentech, Inc.
South San Francisco, California
12.2019 - 04.2020
Led a team of seven Corporate Account Managers focused on B2B relationships across broad healthcare segments, including Medicaid, payers, specialty pharmacies, PBMs, wholesalers/distributors, hemophilia treatment centers, and retail.
Collaborated with leadership to finalize FTE count for full-scale team transformation.
Coordinated with ACM Operations to develop communication strategy for account transition into National Ecosystems, ensuring proactive and coordinated handoff.
Collaborated with the Hemlibra Brand, Squad, and CAM team to define the team's responsibilities with the new Rebate Strategy and agreement roll-out to Hemophilia Treatment Centers.
Coached team members on role adaptation during organizational changes.
Corporate Account Management
Genentech, Inc.
South San Francisco, California
07.2016 - 03.2020
Manage B2B relationships / Business Development towards partnerships across broad, healthcare segments including Medicaid, Payers, Specialty Pharmacies, IDNs, PBMs, Wholesalers/Distributors, HTCs and Retail.
Managed and developed B2B partnerships with key Integrated Health Systems (e.g. Hackensack, Robert Wood Johnson, Thomas Jefferson) resulting in $300m+ Genentech portfolio sales.
Led Executive exchange (CEO) with Thomas Jefferson Health System leading to the execution of Colon Cancer Screening Initiative (e.g. Love Your Colon) within GI department system-wide.
Negotiated, executed and led pull-through contracting with key wholesalers/HTCs /specialty pharmacy and Hemlibra consortiums leading to uptake of product utilization.
ACM Access Advisor Lead for Xofluza. Partnered with Squad/internal stakeholders to develop and execute rebate strategy leading to successful uptake in Xofluza during flu season.
Incorporated co-pay cards into Advent Health EMR system resulting in identification of eligible patients leading to immediate uptake in access.
Received nomination for Account Manager of the Year in 2017, recognizing exceptional performance.
Anthem Blues - National Account Manager (rotation)
Genentech, Inc.
South San Francisco, California
03.2018 - 09.2018
Responsible for engagement with regional Anthem states, developed communication strategy in collaboration with Anthem Team/USMA for proactive and reactive clinical discussions with account and served as point-person for AIM Pathways and internal communication to stakeholders: Brand, Field, MCCO, ACM.
Evolved existing Communication Strategy to inform ACM/Brand Leadership Teams about AIM Pathways, how AIM makes decisions, its impact to Genentech's BioOnc portfolio and account team's strategic approach.
Developed, led and executed the Local Healthcare Market Initiative (e.g. Virginia pilot) for greater understanding of AIM Pathways and better alignment across internal, cross-functional partners contributing to the development of regionalized strategies. Successful outcomes have led to the approval to replicate in another 10 MSAs.
Developed regional profiling of Anthem CMO's in alignment with the broader Anthem Enterprise and created engagement plan in collaboration with USMA partners.
Area Manager - BioOncology Field Reimbursement
Genentech, Inc.
South San Francisco, California
02.2009 - 06.2016
Led team of 7 BioOncology Field Reimbursement Account Managers within the West Region resulting in effective account relationship management focused on reducing reimbursement barriers and ensuring patient access to oncology portfolio.
Led team in effectively launching 10 NMEs into the market place partnering across Access Solutions, Brand and Field contributing to reducing reimbursement barriers leading to patient access.
Co-led Arizona MPS pilot in collaboration with BFRM/Access Solutions resulting in Arizona Oncology Associates moving utilization of Access Solutions patient services from 17% to 79% in 4 months.
Partnered with the team to create the BFRM Preceptorship, leading to greater visibility and understanding of the role of the BFRM, while gaining valuable advocacy that highlights the business impact of the team. (Adopted by the FRM organization)
Led and developed the 2007, 2009, and 2013 'FRMs of the Year.'
FRM Manager of the Year - 2012
Group Product Manager - BioOncology Business Operations
Genentech, Inc.
South San Francisco, California
10.2006 - 02.2009
Led and managed the oncology portfolio and an internal team of five individuals responsible for the strategic coordination across the BioOncology portfolio for key customers, new customer segments, and scientific conferences.
Led Sr. Leading commercial and clinical teams to effective executive exchanges, resulting in clinical master agreements and Phase I-III trial partnerships. (e.g. Johns Hopkins, Duke, Washington University, SCOA.)
Developed organizational strategy for mid-level providers (e.g., pharmacists, fellows, and nurses), collaborating with Brand to align with their customer approach/strategy.
Organizational lead for NCCN, ACSO, and ASHP, responsible for C-Suite engagement, leading to collaborative initiatives.
Recipient of the "Annual Leadership Award" - Marketing Excellence - Leadership of the clinical/commercial team in the development of "alliance agreements."
Recipient of the "Most Innovative Program" award - Marketing Excellence - Development of the Molecular Basis of Cancer Initiative. (MBoC)
Sr. Product Manager - Herceptin Marketing
Genentech, Inc.
South San Francisco, California
09.2004 - 09.2006
Responsible for managing 1 individual leading promotions/strategy for the Herceptin Marketing team and creating overall market strategy and tactics to introduce Herceptin into the adjuvant breast cancer market.
Strategically collaborated with cross-functional teams to effectively develop and roll-out Herceptin Launch Readiness Plan to Sr. Leadership.
Collaborated across Herceptin team to develop and executed the Herceptin Adjuvant Launch strategy across Marketing, Clinical, and Sales resulting in highly successful launch.
Recipient of 2006 Industry "Product Management Team of the Year."
Recipient of 2006 Field Collaboration award.
Herceptin Clinical Oncology Specialist
Genentech, Inc.
South San Francisco, California
09.2003 - 08.2004
Responsible for the clinical promotions of Herceptin in the metastatic (Breast Cancer) setting to oncology HCPs.
Ranked 3rd nationally (PTP) across the Herceptin Franchise in 2004.
Achieved Sales Excellence in 2004.
Assessed as Exceptional Strength in core capabilities in Leadership; Strategic Insight; Communication and Teamwork/Collaboration.
Division Manager
Novartis Pharmaceuticals
East Hanover, New Jersey
08.1990 - 08.2003
Responsible for leading, managing and developing a team of 12 medical sales representatives across 2 sales forces (Sandoz & Geigy) accountable for broad primary care therapeutics to HCPs while leading team through a successful merger.
Director, Global Demand Marketing, NA Field Marketing, ABM and Executive Briefing Program at BMC SoftwareDirector, Global Demand Marketing, NA Field Marketing, ABM and Executive Briefing Program at BMC Software